John Kelley, vice president and show director for CES, poses during an interview at mandalay Bay in Las Vegas, on the sidelines of this year’s CES tech exhibition, Sunday (local time).Courtesy of CTA
Las Vegas is currently buzzing with innovation as korean companies prepare to make a meaningful impact at this year’s Consumer Electronics show (CES). As of january 7, 2026, the event is showcasing a powerful surge in artificial intelligence (AI) and healthcare technologies originating from Korea, signaling a growing global influence. I’ve observed firsthand how crucial these sectors are becoming, and Korea is clearly positioning itself as a leader.
Korean Tech Presence at CES 2026
The commitment of korean businesses to the world’s premier tech showcase remains exceptionally strong.A remarkable 853 Korean firms are participating in CES 2026, establishing it as the third-largest national representation, surpassed only by the United States and China. This substantial presence underscores the importance of the event for Korean companies seeking to expand their reach and demonstrate their latest advancements.
According to the CES Show Director,who also holds the position of vice president at the Consumer Technology Association (CTA),AI is the driving force behind this year’s event. “AI is powering mobility, health care, education – everything,” he stated, highlighting its pervasive influence across various industries. It’s not just about flashy new gadgets; it’s about fundamentally changing how we live and work.
There’s a growing expectation that the Korean government will continue to champion the AI sector, recognizing its potential to reshape national security and economic stability. This support is vital for fostering innovation and ensuring that Korean companies remain competitive on the global stage. I beleive a proactive governmental approach is essential for maximizing the benefits of AI.
Leading Korean corporations like Samsung Electronics, LG Electronics, and Hyundai Motor are all set to unveil their latest AI strategies at the exhibition. Their focus will be on integrating cutting-edge AI technologies into their existing product lines, promising a new wave of intelligent and user-friendly devices. This isn’t simply about adding AI as a feature; it’s about reimagining their core offerings.
Samsung and LG are commanding significant space at the convention center,displaying a range of innovative products and technologies. These companies are consistently pushing the boundaries of what’s possible, and CES provides the perfect platform to showcase their achievements.
Korean startups, particularly those in the healthcare sector, are also making waves. They represent the largest contingent of startups by country at this year’s event,demonstrating the vibrant entrepreneurial ecosystem in Korea.
Did you Know? The healthcare sector is experiencing a surge in investment,with global healthcare spending projected to reach over $10 trillion by 2026,according to Deloitte’s 2024 Global healthcare Outlook.
These startups are developing technologies that promise to improve health outcomes, extend lifespans, and address critical medical challenges. Their contributions are invaluable, and their presence at Eureka Park is a testament to their potential. Furthermore, Korean companies have consistently earned numerous awards for their groundbreaking innovations, solidifying Korea’s reputation as a hub for technological advancement.
The Rise of AI in Healthcare
The convergence of AI and healthcare is particularly exciting. We’re seeing AI-powered diagnostic tools, personalized medicine solutions, and robotic surgery systems that are revolutionizing the way healthcare is delivered. I’ve found that the ability of AI to analyze vast amounts of data and identify patterns is transforming medical research and treatment.
Consider the potential of AI-driven drug finding. Traditionally, developing a new drug can take years and cost billions of dollars. AI can accelerate this process by identifying promising drug candidates and predicting their efficacy, significantly reducing both time and cost. This is a game-changer for the pharmaceutical industry.
Here’s a quick comparison of customary vs. AI-driven drug discovery:
| Feature | Traditional Drug Discovery
Worth a look |
|---|